Allergan fell $6.31 or 3.7 percent, to $165.86. Baxter International Inc. fell $1.40 or 1.8 percent, to $74.69. Boston Scientific Corp. fell$. 36 or 2.7 percent, to $12.78.» Read More
The "Fast Money" traders discuss the market movers that caught their eye this week.
Over the last 20 years, Americans have witnessed unprecedented advances in care of hospitalized patients. Improved diagnostic procedures, quantum leaps in medical technology, enhanced treatments and a public now familiar with the concept of preventative medical care all mean that healthcare – especially in the hospital – has changed to meet the health care needs of today’s patients.
David Cordani, Cigna president & CEO, discusses health care reform and how it is taking shape now.
Finding Qatar on a map may be as difficult as learning how to pronounce the country's name. But analysts say that shouldn't stop investors from targeting the small desert nation—as long as they understand the business culture .
With stocks shrugging off the wall of worry in the first quarter, the second quarter could prove to be a less rewarding time for those long equity markets as central banks begin to tighten policy via rate hikes or withdrawing extraordinary measures.
A selloff may be likely ahead of the end to the Fed's QE2, growth outside the U.S. will lead and technological in health care will attract investors.
Cramer thinks this is it. Check out his interview with this company's CEO.
Telemedicine has attracted major investments from some of the nation's largest companies over the past year. And it has been endorsed by doctors and care takers who believe patients fare better at home.
Why this particular group is hot right now and how Cramer recommends trading it.